{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T19:19:11Z","timestamp":1791227951923,"version":"4.1.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Veterinary Cardiology"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1016\/j.jvc.2012.05.005","type":"journal-article","created":{"date-parts":[[2012,8,2]],"date-time":"2012-08-02T16:19:38Z","timestamp":1343924378000},"page":"399-408","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["Lowered N-terminal pro-B-type natriuretic peptide levels in response to treatment predict survival in dogs with symptomatic mitral valve disease"],"prefix":"10.1016","volume":"14","author":[{"given":"Johanna","family":"Wolf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Gerlach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9","family":"Klima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerhard","family":"Wess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvc.2012.05.005_bib1","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1749-6632.1965.tb49421.x","article-title":"The prevalence and types of cardiovascular disease in dogs","volume":"127","author":"Detweiler","year":"1965","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jvc.2012.05.005_bib2","series-title":"Manual of canine and feline cardiology","first-page":"110","article-title":"Acquired valvular disease","author":"Abott","year":"2008"},{"key":"10.1016\/j.jvc.2012.05.005_bib3","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/j.1939-1676.2002.tb01610.x","article-title":"Efficacy of enalapril for prevention of congestive heart failure in dogs with myxomatous valve disease and asymptomatic mitral regurgitation","volume":"16","author":"Kvart","year":"2002","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.jvc.2012.05.005_bib4","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1939-1676.2007.0008.x","article-title":"Survival characteristics and prognostic variables of dogs with mitral regurgitation attributable to myxomatous valve disease","volume":"22","author":"Borgarelli","year":"2008","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.jvc.2012.05.005_bib5","first-page":"549","article-title":"Chronic valvular disease in the cavalier King Charles spaniel in Sweden","volume":"131","author":"Haggstrom","year":"1992","journal-title":"Vet Rec"},{"key":"10.1016\/j.jvc.2012.05.005_bib6","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1136\/vr.144.12.315","article-title":"Echocardiographic mitral valve prolapse in cavalier King Charles spaniels: epidemiology and prognostic significance for regurgitation","volume":"144","author":"Pedersen","year":"1999","journal-title":"Vet Rec"},{"key":"10.1016\/j.jvc.2012.05.005_bib7","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1136\/vr.152.10.293","article-title":"Early echocardiographic predictors of myxomatous mitral valve disease in dachshunds","volume":"152","author":"Olsen","year":"2003","journal-title":"Vet Rec"},{"key":"10.1016\/j.jvc.2012.05.005_bib8","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1111\/j.1939-1676.2008.0150.x","article-title":"Effect of pimobendan or benazepril hydrochloride on survival times in dogs with congestive heart failure caused by naturally occurring myxomatous mitral valve disease: the QUEST study","volume":"22","author":"Haggstrom","year":"2008","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.jvc.2012.05.005_bib9","series-title":"Textbook of veterinary internal medicine","first-page":"1022","article-title":"Acquired valvular disease","author":"Haggstrom","year":"2005"},{"issue":"Suppl. 1","key":"10.1016\/j.jvc.2012.05.005_bib10","first-page":"39","article-title":"B-type natriuretic peptide: a myocyte-specific marker for characterizing load-induced alterations in cardiac gene expression","volume":"30","author":"Magga","year":"1998","journal-title":"Ann Med"},{"key":"10.1016\/j.jvc.2012.05.005_bib11","doi-asserted-by":"crossref","first-page":"531","DOI":"10.2170\/jjphysiol.40.531","article-title":"Effects of brain natriuretic peptide on hemodynamics and renal function in dogs","volume":"40","author":"Nishida","year":"1990","journal-title":"Jpn J Physiol"},{"key":"10.1016\/j.jvc.2012.05.005_bib12","doi-asserted-by":"crossref","first-page":"20545","DOI":"10.1074\/jbc.272.33.20545","article-title":"Stretch-induced hypertrophic growth of cardiocytes and processing of brain-type natriuretic peptide are controlled by proprotein-processing endoprotease furin","volume":"272","author":"Sawada","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jvc.2012.05.005_bib13","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1161\/01.CIR.80.3.438","article-title":"The N-terminus and a 4000-MW peptide from the midportion of the N-terminus of the atrial natriuretic factor prohormone each circulate in humans and increase in congestive heart failure","volume":"80","author":"Winters","year":"1989","journal-title":"Circulation"},{"key":"10.1016\/j.jvc.2012.05.005_bib14","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1748-5827.2007.00510.x","article-title":"The diagnostic accuracy of different natriuretic peptides in the investigation of canine cardiac disease","volume":"49","author":"Boswood","year":"2008","journal-title":"J Small Anim Pract"},{"key":"10.1016\/j.jvc.2012.05.005_bib15","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.2460\/javma.232.11.1674","article-title":"Evaluation of circulating amino terminal-pro-B-type natriuretic peptide concentration in dogs with respiratory distress attributable to congestive heart failure or primary pulmonary disease","volume":"232","author":"Fine","year":"2008","journal-title":"J Am Vet Med Assoc"},{"key":"10.1016\/j.jvc.2012.05.005_bib16","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.2460\/javma.232.10.1496","article-title":"Clinical utility of serum N-terminal pro-B-type natriuretic peptide concentration for identifying cardiac disease in dogs and assessing disease severity","volume":"232","author":"Oyama","year":"2008","journal-title":"J Am Vet Med Assoc"},{"key":"10.1016\/j.jvc.2012.05.005_bib17","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/j.1939-1676.2003.tb02430.x","article-title":"Brain natriuretic peptide concentration in dogs with heart disease and congestive heart failure","volume":"17","author":"MacDonald","year":"2003","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.jvc.2012.05.005_bib18","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jvc.2009.07.001","article-title":"Plasma N-terminal pro-B-type natriuretic peptide concentration helps to predict survival in dogs with symptomatic degenerative mitral valve disease regardless of and in combination with the initial clinical status at admission","volume":"11","author":"Serres","year":"2009","journal-title":"J Vet Cardiol"},{"key":"10.1016\/j.jvc.2012.05.005_bib19","first-page":"293","article-title":"Measurement of plasma atrial natriuretic peptide as an indicator of prognosis in dogs with cardiac disease","volume":"44","author":"Greco","year":"2003","journal-title":"Can Vet J"},{"key":"10.1016\/j.jvc.2012.05.005_bib20","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/j.1748-5827.2009.00889.x","article-title":"N-terminal pro B-type natriuretic peptide and left ventricular diameter independently predict mortality in dogs with mitral valve disease","volume":"51","author":"Moonarmart","year":"2010","journal-title":"J Small Anim Pract"},{"key":"10.1016\/j.jvc.2012.05.005_bib21","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.cardfail.2008.11.007","article-title":"Reduction in BNP levels with treatment of decompensated heart failure and future clinical events","volume":"15","author":"Dhaliwal","year":"2009","journal-title":"J Card Fail"},{"key":"10.1016\/j.jvc.2012.05.005_bib22","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/S0735-1097(00)01157-8","article-title":"A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: a pilot study","volume":"37","author":"Cheng","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jvc.2012.05.005_bib23","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.jacc.2003.09.044","article-title":"Predischarge B-type natriuretic peptide assay for identifying patients at high risk of re-admission after decompensated heart failure","volume":"43","author":"Logeart","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jvc.2012.05.005_bib24","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1161\/01.CIR.0000144310.04433.BE","article-title":"N-terminal-pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients","volume":"110","author":"Bettencourt","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jvc.2012.05.005_bib25","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1016\/j.jacc.2009.02.058","article-title":"Lowered B-type natriuretic peptide in response to levosimendan or dobutamine treatment is associated with improved survival in patients with severe acutely decompensated heart failure","volume":"53","author":"Cohen-Solal","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jvc.2012.05.005_bib26","unstructured":"H\u00e4ggstr\u00f6m J. Heart disease versus heart failure: staging of cardiac disease (proceedings). In: British small animal veterinary congress; 2009."},{"key":"10.1016\/j.jvc.2012.05.005_bib27","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1111\/j.1740-8261.2002.tb01051.x","article-title":"Left atrial to aortic root indices using two-dimensional and M-mode echocardiography in cavalier King Charles spaniels with and without left atrial enlargement","volume":"43","author":"Hansson","year":"2002","journal-title":"Vet Radiol Ultrasound"},{"key":"10.1016\/j.jvc.2012.05.005_bib28","doi-asserted-by":"crossref","first-page":"994","DOI":"10.2460\/ajvr.2002.63.994","article-title":"Linear, logarithmic, and polynomial models of M-mode echocardiographic measurements in dogs","volume":"63","author":"Goncalves","year":"2002","journal-title":"Am J Vet Res"},{"key":"10.1016\/j.jvc.2012.05.005_bib29","first-page":"311","article-title":"Allometric scaling of M-mode cardiac measurements in normal adult dogs","volume":"18","author":"Cornell","year":"2004","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.jvc.2012.05.005_bib30","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.tvjl.2007.07.002","article-title":"Analytical validation of commercial immunoassays for the measurement of cardiovascular peptides in the dog","volume":"178","author":"Schellenberg","year":"2008","journal-title":"Vet J"},{"key":"10.1016\/j.jvc.2012.05.005_bib31","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/S0140-6736(00)02060-2","article-title":"Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations","volume":"355","author":"Troughton","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.jvc.2012.05.005_bib32","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1016\/j.jacc.2006.10.081","article-title":"Plasma brain natriuretic peptide-guided therapy to improve outcome in heart failure: the STARS-BNP multicenter study","volume":"49","author":"Jourdain","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jvc.2012.05.005_bib33","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1053\/euhj.1999.1746","article-title":"Plasma brain natriuretic peptide level as a biochemical marker of morbidity and mortality in patients with asymptomatic or minimally symptomatic left ventricular dysfunction. Comparison with plasma angiotensin II and endothelin-1","volume":"20","author":"Tsutamoto","year":"1999","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jvc.2012.05.005_bib34","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/S0735-1097(01)01383-3","article-title":"Prognostic evaluation of neurohumoral plasma levels before and during beta-blocker therapy in advanced left ventricular dysfunction","volume":"38","author":"Stanek","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jvc.2012.05.005_bib35","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1016\/j.ehj.2003.07.005","article-title":"N-terminal pro-brain natriuretic peptide. A new gold standard in predicting mortality in patients with advanced heart failure","volume":"24","author":"Gardner","year":"2003","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jvc.2012.05.005_bib36","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.cardfail.2006.09.003","article-title":"The biologic variability of B-type natriuretic peptide and N-terminal pro-B-type natriuretic peptide in stable heart failure patients","volume":"13","author":"O'Hanlon","year":"2007","journal-title":"J Card Fail"},{"key":"10.1016\/j.jvc.2012.05.005_bib37","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1373\/clinchem.2004.038752","article-title":"High intraindividual variation of B-type natriuretic peptide (BNP) and amino-terminal proBNP in patients with stable chronic heart failure","volume":"50","author":"Bruins","year":"2004","journal-title":"Clin Chem"}],"container-title":["Journal of Veterinary Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1760273412000872?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1760273412000872?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T02:37:20Z","timestamp":1761705440000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1760273412000872"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["S1760273412000872"],"URL":"https:\/\/doi.org\/10.1016\/j.jvc.2012.05.005","relation":{},"ISSN":["1760-2734"],"issn-type":[{"value":"1760-2734","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lowered N-terminal pro-B-type natriuretic peptide levels in response to treatment predict survival in dogs with symptomatic mitral valve disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Veterinary Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvc.2012.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}